-
Eisai Representative Corporate Officer And CEO Haruo Naito Awarded The Order Of The Rising Sun, Gold And Silver Star
30 Apr 2025 18:50 GMT
… the development of innovative new drugs, including Alzheimer's disease … various institutional reforms, including the drug pricing system and R… , Eisai (current)
Industry Association History
May 1998 - Vice President, Japan Pharmaceutical …
-
Lecanemab: Experts criticise European Commission approval of Alzheimer’s drug
30 Apr 2025 06:54 GMT
… s drug lecanemab (Leqembi) despite uncertain benefits.
Lecanemab, manufactured by Eisai, … is the first disease modifying drug to treat … authorisation request for the drug on the grounds that … decision to recommend the drug.3
On 15 April …
-
Phenylketonuria Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
29 Apr 2025 17:00 GMT
… the recent advances in phenylketonuria drugs @ Phenylketonuria Pipeline Report The phenylketonuria … Inc., Eisai Inc., Hoffmann-La Roche, Ionis Pharmaceuticals, Inc., Otsuka Pharmaceutical Co., Ltd …
-
Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025
25 Apr 2025 12:00 GMT
… Phase 2 clinical-stage pharmaceutical company dedicated to developing … treatment using its proprietary, drug-specific Drug Response Predictor (DRP®) … exclusively for small-molecule drugs. This new predictor … was originally developed by Eisai Co. Ltd. and was …
-
Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight
30 Apr 2025 17:00 GMT
… #47;HER2- Breast Cancer Drugs
Competitive Intelligence Analysis: SWOT … the pipeline landscape, pipeline drug profiles, including clinical and … Eisai Inc., Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Simcere Pharmaceutical Co., Kind Pharmaceuticals, …
-
Epigenetics Drugs And Diagnostic Technologies Market anticipated to surpass $53.345 billion by 2030 at a CAGR of 15.21%
22 Apr 2025 11:58 GMT
… pharmaceutical companies and research institutions to develop new and innovative epigenetic drugs … Dovetail Genomics LLC., Abcam plc., Eisai Co., Ltd., Novartis AG, Cantata …
• Dovetail Genomics LLC.
• Abcam plc.
• Eisai Co., Ltd.
• Novartis AG
• Cantata …
-
AAN 2025: Pharmacists Play Critical Role in Monitoring, Managing Lecanemab Therapy
20 Apr 2025 14:12 GMT
… (AD) recommended for lecanemab (Leqembi; Eisai) therapy within the NYU Langone … that pharmacists are essential in monitoring dosing schedules, checking for potential drug …
-
Fierce Pharma Asia—The latest on Trump's tariffs; Leqembi's EU approval; Kyowa Kirin's biologics plant
18 Apr 2025 17:27 GMT
… The European Commission has approved Eisai and Biogen's Leqembi … In short reprieve for pharma, commerce secretary says drug tariffs to come … t bear large tariffs.
2. Eisai, Biogen's Alzheimer… months of back and forth, Eisai and Biogen’s Leqembi has …
-
After delay, Alzheimer's drug Leqembi gets green light in EU
16 Apr 2025 10:56 GMT
… , associated with amyloid-targeting drugs, than people with two … measures are applied."
Eisai and Biogen said that … contrast to previously approved drugs that boost neurotransmitters in the … the drug has proven to be sluggish, although, Eisai has …
-
EU conditionally approves new Alzheimer’s drug
16 Apr 2025 19:23 GMT
… multinational Biogen and Japanese-based Eisai, is the brand name of … .
The EMA endorsed the drug only for patients with a … together with another Alzheimer’s drug called Aduhelm, received approval from … the US Food and Drug Administration in 2023.
News.Az …
About
© 1995-2025